UBS Group AG

Q3 2022 13F-HR Holdings

Location
Zurich, V8
Holdings as of
9/30/2022
Date filed
11/10/2022
Form type
13F-HR
Num holdings
10,856
Total value ($000)
$228,092,861
Net value change ($000)
-15,433,895 (-6.3%)
New positions
882
Sold out positions
810
Turnover %
0.5%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 8/10/2022 Next filing: 2/8/2023 SEC filing

Snapshot: Change Analysis

Compared to Q2 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
XLE 234,964 32.9%
BIL 138,272 39.6%
IEF 125,865 90.1%
XLV 115,204 24.6%
SPY 111,477 3.3%
PANW 109,910 41.5%
VRT 96,273 106.6%
USFR 91,386 70.3%
Biohaven Pharmaceutical Holding Co Ltd. 86,066 215.5%
FXE 80,622 244.9%
Top Reduces (Value $000, Stocks/ETFs)
MSFT -783,654 -12.1%
QQQ -629,661 -32.1%
ACWI -629,401 -73.4%
GOOGL -524,569 -20.2%
IVV -412,630 -27.2%
NVDA -319,535 -31.4%
BABA -298,301 -63.2%
GOOGL -296,092 -18.9%
INTC -256,342 -28.5%
PFE -243,388 -27.2%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 52,977,582 (23.2% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type